Physician profile
Ryan Earle
NPI 1699319384
$2,605.91
in general payments reported to CMS, 2019-2025
22 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $389 · 2022: $486 · 2023: $644 · 2024: $745 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $475.89 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $465.13 | 2021-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $318.35 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.11 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $233.86 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $224.43 | 2021-2023 | Belsomra, Steglatro |
| Pfizer INC. | $199.15 | 2021-2024 | |
| Mylan Specialty L.P. | $98.33 | 2021-2023 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $59.05 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $36.15 | 2023-2024 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.94 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $25.05 | 2021-2022 | |
| Abbvie INC. | $24.46 | 2021-2024 | |
| Corcept Therapeutics | $21.12 | 2024 | Korlym |
| Amarin Pharma, INC. | $18.05 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $15.97 | 2023 | Iovera, Zilretta |
| Astrazeneca Pharmaceuticals LP | $15.59 | 2023 | Breztri |
| Exact Sciences Corporation | $14.10 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $14.09 | 2024 | |
| Lundbeck LLC | $13.98 | 2022 | |
| Genentech USA, INC. | $11.99 | 2021 | |
| Orthofix Medical, INC. | $11.12 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Earle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.